TCS and MIT Sloan launch research series, unveil roadmap for human-AI collaboration in enterprises
Tata Consultancy Services (TCS) and MIT Sloan Management Review (MIT SMR) have announced a collaborative research series exploring the evolving relationship between humans and AI in enterprises. The findings reveal that artificial intelligence (AI) is moving beyond its traditional role as a support tool and emerging as an architect of strategic business decisions.
In a year-long, multi-sector study covering industries like manufacturing, retail, BFSI, healthcare, energy, and technology, TCS and MIT SMR examined how generative and predictive AI are transforming decision-making. The research involved leaders from companies like Walmart, Meta, Mastercard, and Pernod Ricard, uncovering how AI-enabled 'Intelligent Choice Architectures' (ICAs) are being used to improve organizational decisions.
The study identifies a paradigm shift: AI now helps create better decision environments rather than simply automating tasks. These ICAs support enterprises in making smarter, faster, and more accountable choices by predicting outcomes, suggesting options, and clarifying trade-offs.
Some notable examples include: Retail: Walmart and Pernod Ricard use ICAs to personalize customer experiences, identify talent, and refine marketing campaigns.
Manufacturing: Companies like Cummins are using generative AI to simulate extreme product design scenarios and optimize supply chains.
BFSI: Mastercard and Liberty Mutual leverage ICAs for fraud prevention, compliance, and improved customer care.
Healthcare: ICAs assist scientists in drug discovery and diagnostics, cutting discovery times and costs significantly.
Telecom: BT uses an AI assistant named 'Aimee' to handle customer interactions, while Meta integrates ICAs to accelerate product decisions.
According to Ashok Krish, Head of AI Practice at TCS, 'ICAs shift AI from task automation to building superior decision environments for complex situations, ensuring trackable, traceable outcomes that align with organizational goals.'
This initiative builds on TCS's ongoing collaboration with MIT SMR, extending its focus to creating human-centric AI systems that foster transparent, informed, and accountable decision-making.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
11 hours ago
- Business Upturn
Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India
By Aditya Bhagchandani Published on July 16, 2025, 17:23 IST Emcure Pharmaceuticals Ltd. and Sanofi India Ltd. (SIL) have announced an exclusive distribution and promotion agreement for Sanofi's oral anti-diabetic (OAD) products in India, effective immediately. Under this partnership, Emcure will distribute and promote SIL's widely prescribed OAD brands, including Amaryl® and Cetapin®, leveraging its deep reach and network across India. Sanofi will continue to own and manufacture these products at its plants in India and globally. The collaboration aims to expand access to trusted oral diabetes medicines to millions of patients across the country. Notably, there will be no employee transfers from Sanofi to Emcure as part of this deal. Eric Mansion, GM Pharma Southeast Asia and India at Sanofi, said: 'Over 100 million Indians live with type 2 diabetes, and more than 60% have uncontrolled blood sugar levels. With Emcure's reach, we aim to unlock the full potential of our industry-leading OADs for patients and healthcare professionals.' Satish Mehta, CEO & MD of Emcure, added: 'This partnership aligns with our mission to improve patient access to high-quality therapies and complements our existing diabetes portfolio, supporting better diabetes care nationwide.' This alliance brings together Sanofi's strong brand portfolio and Emcure's extensive distribution network, strengthening both companies' presence in the critical diabetes care segment. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
11 hours ago
- Business Upturn
Hindustan Zinc secures LoI for Rajasthan potash and halite block
Hindustan Zinc Limited (HZL) announced on July 16, 2025, that it has received a Letter of Intent (LoI) from the Ministry of Mines, Government of India, confirming it as the preferred bidder for the Jhandawali–Satipura Amalgamated Potash and Halite Block in Rajasthan. The LoI was issued under Rule 18(1) of the Mineral Auction Rules, 2015, following an e-auction conducted by the ministry. The block, located in Hanumangarh district, Rajasthan, spans an area of approximately 1,841.25 hectares and will be granted to HZL as a composite license (covering both prospecting and mining). This acquisition is aligned with HZL's strategy to diversify into other minerals and expand its resource base beyond zinc and lead. The company had earlier intimated about its bid through a letter dated May 28, 2025, and the receipt of the LoI marks the next step toward operationalizing this resource. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
11 hours ago
- Business Upturn
Godawari Power & Ispat gets environment clearance for 2 MTPA integrated steel plant in Raipur
By Aditya Bhagchandani Published on July 16, 2025, 18:20 IST Godawari Power & Ispat Ltd (GPIL) announced on July 16, 2025, that it has received the much-awaited environment clearance from the Ministry of Environment, Forest & Climate Change, Government of India for setting up a 2 million tonnes per annum (MTPA) integrated steel plant. The clearance was granted by the ministry's Impact Assessment Division — Industrial Projects during the 7th meeting of the Expert Appraisal Committee (EAC) held on July 9, 2025, with the minutes uploaded to the ministry's website on July 16. The proposed plant, with 2×1 MTPA modules, will be located at Village Sarora, Tahsil Tilda, District Raipur, Chhattisgarh. This approval marks a significant milestone in GPIL's expansion plans to strengthen its presence in India's steel sector while ensuring compliance with environmental and sustainability standards. The company has requested exchanges to take this information on record as per SEBI (LODR) Regulations, 2015. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
